nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—ALB—Crohn's disease	0.48	1	CbGaD
Ceftriaxone—SLC22A8—Mercaptopurine—Crohn's disease	0.188	0.721	CbGbCtD
Ceftriaxone—ALB—Prednisone—Crohn's disease	0.0728	0.279	CbGbCtD
Ceftriaxone—Drug fever—Mercaptopurine—Crohn's disease	0.00803	0.0527	CcSEcCtD
Ceftriaxone—Alveolitis allergic—Mesalazine—Crohn's disease	0.00557	0.0366	CcSEcCtD
Ceftriaxone—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0055	0.0947	CbGpPWpGaD
Ceftriaxone—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0055	0.0947	CbGpPWpGaD
Ceftriaxone—Secondary infection—Azathioprine—Crohn's disease	0.00544	0.0357	CcSEcCtD
Ceftriaxone—GLUL—gall bladder—Crohn's disease	0.00507	0.129	CbGeAlD
Ceftriaxone—GLUL—mouth—Crohn's disease	0.00451	0.115	CbGeAlD
Ceftriaxone—Drug fever—Mesalazine—Crohn's disease	0.00436	0.0286	CcSEcCtD
Ceftriaxone—Glossodynia—Mesalazine—Crohn's disease	0.00436	0.0286	CcSEcCtD
Ceftriaxone—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0042	0.0722	CbGpPWpGaD
Ceftriaxone—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0042	0.0722	CbGpPWpGaD
Ceftriaxone—Haematocrit decreased—Mesalazine—Crohn's disease	0.00391	0.0256	CcSEcCtD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—KSR1—Crohn's disease	0.00358	0.0617	CbGpPWpGaD
Ceftriaxone—Cholestasis—Mercaptopurine—Crohn's disease	0.00353	0.0232	CcSEcCtD
Ceftriaxone—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0035	0.0603	CbGpPWpGaD
Ceftriaxone—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0035	0.0603	CbGpPWpGaD
Ceftriaxone—ALB—gall bladder—Crohn's disease	0.00314	0.0801	CbGeAlD
Ceftriaxone—Lactic dehydrogenase activity increased—Mesalazine—Crohn's disease	0.00284	0.0187	CcSEcCtD
Ceftriaxone—Local reaction—Mesalazine—Crohn's disease	0.00263	0.0173	CcSEcCtD
Ceftriaxone—GLUL—epithelium—Crohn's disease	0.00262	0.0669	CbGeAlD
Ceftriaxone—Candida infection—Mercaptopurine—Crohn's disease	0.00256	0.0168	CcSEcCtD
Ceftriaxone—Nephropathy toxic—Mesalazine—Crohn's disease	0.00253	0.0166	CcSEcCtD
Ceftriaxone—GLUL—smooth muscle tissue—Crohn's disease	0.00253	0.0645	CbGeAlD
Ceftriaxone—Blood lactate dehydrogenase increased—Mesalazine—Crohn's disease	0.0025	0.0164	CcSEcCtD
Ceftriaxone—GLUL—skin of body—Crohn's disease	0.00249	0.0636	CbGeAlD
Ceftriaxone—Thrombocytosis—Mesalazine—Crohn's disease	0.00234	0.0154	CcSEcCtD
Ceftriaxone—Cholelithiasis—Mesalazine—Crohn's disease	0.00234	0.0154	CcSEcCtD
Ceftriaxone—SLC15A2—mouth—Crohn's disease	0.00233	0.0594	CbGeAlD
Ceftriaxone—GLUL—mammalian vulva—Crohn's disease	0.00228	0.058	CbGeAlD
Ceftriaxone—SLC15A1—epithelium—Crohn's disease	0.00217	0.0553	CbGeAlD
Ceftriaxone—Cholestasis—Azathioprine—Crohn's disease	0.0021	0.0138	CcSEcCtD
Ceftriaxone—SLC22A11—digestive system—Crohn's disease	0.0021	0.0536	CbGeAlD
Ceftriaxone—GLUL—lymphoid tissue—Crohn's disease	0.00202	0.0515	CbGeAlD
Ceftriaxone—GLUL—digestive system—Crohn's disease	0.002	0.0509	CbGeAlD
Ceftriaxone—Dermatitis atopic—Mesalazine—Crohn's disease	0.00197	0.0129	CcSEcCtD
Ceftriaxone—Cholestasis—Mesalazine—Crohn's disease	0.00192	0.0126	CcSEcCtD
Ceftriaxone—SLC15A1—mammalian vulva—Crohn's disease	0.00188	0.048	CbGeAlD
Ceftriaxone—Feeling hot—Mesalazine—Crohn's disease	0.00185	0.0122	CcSEcCtD
Ceftriaxone—Tenderness—Mesalazine—Crohn's disease	0.00167	0.011	CcSEcCtD
Ceftriaxone—Proteinuria—Mesalazine—Crohn's disease	0.00166	0.0109	CcSEcCtD
Ceftriaxone—SLC15A1—digestive system—Crohn's disease	0.00165	0.0421	CbGeAlD
Ceftriaxone—Pancreatitis—Mercaptopurine—Crohn's disease	0.00165	0.0108	CcSEcCtD
Ceftriaxone—Protein urine present—Mesalazine—Crohn's disease	0.00163	0.0107	CcSEcCtD
Ceftriaxone—Leukocytosis—Mesalazine—Crohn's disease	0.00155	0.0102	CcSEcCtD
Ceftriaxone—Colitis—Azathioprine—Crohn's disease	0.00153	0.0101	CcSEcCtD
Ceftriaxone—Lymphopenia—Prednisone—Crohn's disease	0.0015	0.00988	CcSEcCtD
Ceftriaxone—Aplastic anaemia—Azathioprine—Crohn's disease	0.0015	0.00985	CcSEcCtD
Ceftriaxone—Stomatitis—Mercaptopurine—Crohn's disease	0.00146	0.0096	CcSEcCtD
Ceftriaxone—Vaginal inflammation—Mesalazine—Crohn's disease	0.00146	0.00956	CcSEcCtD
Ceftriaxone—Cephaloglycin—SLC22A5—Crohn's disease	0.00141	0.15	CrCbGaD
Ceftriaxone—Colitis—Mesalazine—Crohn's disease	0.0014	0.00917	CcSEcCtD
Ceftriaxone—Candida infection—Mesalazine—Crohn's disease	0.00139	0.00912	CcSEcCtD
Ceftriaxone—Vaginal infection—Mesalazine—Crohn's disease	0.00137	0.00902	CcSEcCtD
Ceftriaxone—Aplastic anaemia—Mesalazine—Crohn's disease	0.00137	0.00897	CcSEcCtD
Ceftriaxone—Cefepime—SLC22A5—Crohn's disease	0.00134	0.142	CrCbGaD
Ceftriaxone—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00133	0.00871	CcSEcCtD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—TNFRSF1B—Crohn's disease	0.00133	0.0228	CbGpPWpGaD
Ceftriaxone—Hypertonia—Mesalazine—Crohn's disease	0.00128	0.00838	CcSEcCtD
Ceftriaxone—GLUL—lymph node—Crohn's disease	0.00114	0.0291	CbGeAlD
Ceftriaxone—Renal impairment—Mesalazine—Crohn's disease	0.00111	0.00729	CcSEcCtD
Ceftriaxone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.0011	0.019	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.0011	0.019	CbGpPWpGaD
Ceftriaxone—Anaemia—Mercaptopurine—Crohn's disease	0.00108	0.00711	CcSEcCtD
Ceftriaxone—Leukopenia—Mercaptopurine—Crohn's disease	0.00105	0.00689	CcSEcCtD
Ceftriaxone—Cefixime—SLC22A5—Crohn's disease	0.00105	0.111	CrCbGaD
Ceftriaxone—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.00104	0.00686	CcSEcCtD
Ceftriaxone—Dermatitis atopic—Prednisone—Crohn's disease	0.00104	0.00683	CcSEcCtD
Ceftriaxone—Fungal infection—Prednisone—Crohn's disease	0.000997	0.00655	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Mesalazine—Crohn's disease	0.000989	0.0065	CcSEcCtD
Ceftriaxone—Ceftazidime—SLC22A5—Crohn's disease	0.000983	0.104	CrCbGaD
Ceftriaxone—Pancreatitis—Azathioprine—Crohn's disease	0.000983	0.00645	CcSEcCtD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—TAB1—Crohn's disease	0.000968	0.0167	CbGpPWpGaD
Ceftriaxone—Cefdinir—SLC22A5—Crohn's disease	0.000965	0.102	CrCbGaD
Ceftriaxone—Abdominal pain upper—Mesalazine—Crohn's disease	0.000965	0.00633	CcSEcCtD
Ceftriaxone—Oedema—Mercaptopurine—Crohn's disease	0.000957	0.00628	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.000951	0.00625	CcSEcCtD
Ceftriaxone—Glycosuria—Prednisone—Crohn's disease	0.00095	0.00624	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000937	0.00615	CcSEcCtD
Ceftriaxone—Eosinophilia—Mesalazine—Crohn's disease	0.000904	0.00594	CcSEcCtD
Ceftriaxone—Bronchospasm—Mesalazine—Crohn's disease	0.000898	0.0059	CcSEcCtD
Ceftriaxone—Pancreatitis—Mesalazine—Crohn's disease	0.000895	0.00588	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000886	0.00582	CcSEcCtD
Ceftriaxone—Neutropenia—Mesalazine—Crohn's disease	0.000854	0.00561	CcSEcCtD
Ceftriaxone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000841	0.0145	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000841	0.0145	CbGpPWpGaD
Ceftriaxone—Agranulocytosis—Azathioprine—Crohn's disease	0.000834	0.00548	CcSEcCtD
Ceftriaxone—Leukocytosis—Prednisone—Crohn's disease	0.000819	0.00538	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000807	0.0053	CcSEcCtD
Ceftriaxone—Haemoglobin—Azathioprine—Crohn's disease	0.000806	0.00529	CcSEcCtD
Ceftriaxone—Haemorrhage—Azathioprine—Crohn's disease	0.000802	0.00527	CcSEcCtD
Ceftriaxone—Cefdinir—MPO—Crohn's disease	0.000801	0.0851	CrCbGaD
Ceftriaxone—Renal failure—Mesalazine—Crohn's disease	0.0008	0.00525	CcSEcCtD
Ceftriaxone—Stomatitis—Mesalazine—Crohn's disease	0.000793	0.00521	CcSEcCtD
Ceftriaxone—Jaundice—Mesalazine—Crohn's disease	0.000793	0.00521	CcSEcCtD
Ceftriaxone—Haematuria—Mesalazine—Crohn's disease	0.000776	0.0051	CcSEcCtD
Ceftriaxone—Epistaxis—Mesalazine—Crohn's disease	0.000768	0.00504	CcSEcCtD
Ceftriaxone—Agranulocytosis—Mesalazine—Crohn's disease	0.00076	0.00499	CcSEcCtD
Ceftriaxone—Erythema multiforme—Azathioprine—Crohn's disease	0.000758	0.00498	CcSEcCtD
Ceftriaxone—Body temperature increased—Mercaptopurine—Crohn's disease	0.000756	0.00497	CcSEcCtD
Ceftriaxone—Haemoglobin—Mesalazine—Crohn's disease	0.000734	0.00482	CcSEcCtD
Ceftriaxone—Haemorrhage—Mesalazine—Crohn's disease	0.000731	0.0048	CcSEcCtD
Ceftriaxone—Chills—Azathioprine—Crohn's disease	0.00072	0.00473	CcSEcCtD
Ceftriaxone—ALB—lymph node—Crohn's disease	0.000706	0.018	CbGeAlD
Ceftriaxone—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000705	0.00463	CcSEcCtD
Ceftriaxone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000702	0.0121	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000702	0.0121	CbGpPWpGaD
Ceftriaxone—Erythema multiforme—Mesalazine—Crohn's disease	0.000691	0.00454	CcSEcCtD
Ceftriaxone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000687	0.0118	CbGpPWpGaD
Ceftriaxone—Hyperkinesia—Prednisone—Crohn's disease	0.000671	0.00441	CcSEcCtD
Ceftriaxone—Chills—Mesalazine—Crohn's disease	0.000656	0.00431	CcSEcCtD
Ceftriaxone—Diarrhoea—Mercaptopurine—Crohn's disease	0.000654	0.0043	CcSEcCtD
Ceftriaxone—Cefalotin—SLC22A5—Crohn's disease	0.000653	0.0693	CrCbGaD
Ceftriaxone—Ill-defined disorder—Azathioprine—Crohn's disease	0.000648	0.00425	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Prednisone—Crohn's disease	0.000646	0.00424	CcSEcCtD
Ceftriaxone—Anaemia—Azathioprine—Crohn's disease	0.000645	0.00424	CcSEcCtD
Ceftriaxone—Malaise—Azathioprine—Crohn's disease	0.00063	0.00414	CcSEcCtD
Ceftriaxone—Flatulence—Mesalazine—Crohn's disease	0.000627	0.00412	CcSEcCtD
Ceftriaxone—Leukopenia—Azathioprine—Crohn's disease	0.000625	0.0041	CcSEcCtD
Ceftriaxone—Dysgeusia—Mesalazine—Crohn's disease	0.000623	0.00409	CcSEcCtD
Ceftriaxone—Vomiting—Mercaptopurine—Crohn's disease	0.000608	0.00399	CcSEcCtD
Ceftriaxone—Rash—Mercaptopurine—Crohn's disease	0.000603	0.00396	CcSEcCtD
Ceftriaxone—Dermatitis—Mercaptopurine—Crohn's disease	0.000603	0.00396	CcSEcCtD
Ceftriaxone—Cefotetan—ALB—Crohn's disease	0.000594	0.063	CrCbGaD
Ceftriaxone—Ill-defined disorder—Mesalazine—Crohn's disease	0.00059	0.00388	CcSEcCtD
Ceftriaxone—SLC15A2—lymph node—Crohn's disease	0.000589	0.015	CbGeAlD
Ceftriaxone—Anaemia—Mesalazine—Crohn's disease	0.000588	0.00386	CcSEcCtD
Ceftriaxone—Discomfort—Azathioprine—Crohn's disease	0.000587	0.00386	CcSEcCtD
Ceftriaxone—Malaise—Mesalazine—Crohn's disease	0.000574	0.00377	CcSEcCtD
Ceftriaxone—Leukopenia—Mesalazine—Crohn's disease	0.000569	0.00374	CcSEcCtD
Ceftriaxone—Nausea—Mercaptopurine—Crohn's disease	0.000568	0.00373	CcSEcCtD
Ceftriaxone—Infection—Azathioprine—Crohn's disease	0.000566	0.00372	CcSEcCtD
Ceftriaxone—Palpitations—Mesalazine—Crohn's disease	0.000562	0.00369	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Azathioprine—Crohn's disease	0.000558	0.00366	CcSEcCtD
Ceftriaxone—Discomfort—Mesalazine—Crohn's disease	0.000535	0.00351	CcSEcCtD
Ceftriaxone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000524	0.00901	CbGpPWpGaD
Ceftriaxone—Anaphylactic shock—Mesalazine—Crohn's disease	0.000519	0.00341	CcSEcCtD
Ceftriaxone—Oedema—Mesalazine—Crohn's disease	0.000519	0.00341	CcSEcCtD
Ceftriaxone—Cefpiramide—ALB—Crohn's disease	0.000517	0.0548	CrCbGaD
Ceftriaxone—Infection—Mesalazine—Crohn's disease	0.000516	0.00339	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Mesalazine—Crohn's disease	0.000508	0.00334	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Mesalazine—Crohn's disease	0.000502	0.0033	CcSEcCtD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000501	0.00862	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000501	0.00862	CbGpPWpGaD
Ceftriaxone—Pancreatitis—Prednisone—Crohn's disease	0.000474	0.00311	CcSEcCtD
Ceftriaxone—Sweating increased—Prednisone—Crohn's disease	0.00047	0.00309	CcSEcCtD
Ceftriaxone—Feeling abnormal—Azathioprine—Crohn's disease	0.00047	0.00308	CcSEcCtD
Ceftriaxone—Paraesthesia—Mesalazine—Crohn's disease	0.000466	0.00306	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000466	0.00306	CcSEcCtD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000463	0.00797	CbGpPWpGaD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000463	0.00797	CbGpPWpGaD
Ceftriaxone—Dyspepsia—Mesalazine—Crohn's disease	0.000457	0.003	CcSEcCtD
Ceftriaxone—Neutropenia—Prednisone—Crohn's disease	0.000452	0.00297	CcSEcCtD
Ceftriaxone—Abdominal pain—Azathioprine—Crohn's disease	0.000451	0.00296	CcSEcCtD
Ceftriaxone—Body temperature increased—Azathioprine—Crohn's disease	0.000451	0.00296	CcSEcCtD
Ceftriaxone—Cefonicid—ALB—Crohn's disease	0.00045	0.0478	CrCbGaD
Ceftriaxone—Pain—Mesalazine—Crohn's disease	0.000444	0.00292	CcSEcCtD
Ceftriaxone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000437	0.00752	CbGpPWpGaD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00043	0.00739	CbGpPWpGaD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00043	0.00739	CbGpPWpGaD
Ceftriaxone—Feeling abnormal—Mesalazine—Crohn's disease	0.000428	0.00281	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000425	0.00279	CcSEcCtD
Ceftriaxone—Hypersensitivity—Azathioprine—Crohn's disease	0.00042	0.00276	CcSEcCtD
Ceftriaxone—Urticaria—Mesalazine—Crohn's disease	0.000412	0.00271	CcSEcCtD
Ceftriaxone—Body temperature increased—Mesalazine—Crohn's disease	0.00041	0.00269	CcSEcCtD
Ceftriaxone—Abdominal pain—Mesalazine—Crohn's disease	0.00041	0.00269	CcSEcCtD
Ceftriaxone—Diarrhoea—Azathioprine—Crohn's disease	0.00039	0.00256	CcSEcCtD
Ceftriaxone—Haemoglobin—Prednisone—Crohn's disease	0.000389	0.00255	CcSEcCtD
Ceftriaxone—Haemorrhage—Prednisone—Crohn's disease	0.000387	0.00254	CcSEcCtD
Ceftriaxone—Hypersensitivity—Mesalazine—Crohn's disease	0.000382	0.00251	CcSEcCtD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000382	0.00657	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000382	0.00657	CbGpPWpGaD
Ceftriaxone—Dizziness—Azathioprine—Crohn's disease	0.000377	0.00247	CcSEcCtD
Ceftriaxone—Pruritus—Mesalazine—Crohn's disease	0.000367	0.00241	CcSEcCtD
Ceftriaxone—Vomiting—Azathioprine—Crohn's disease	0.000362	0.00238	CcSEcCtD
Ceftriaxone—ALB—Folate Metabolism—GPX4—Crohn's disease	0.000362	0.00623	CbGpPWpGaD
Ceftriaxone—Rash—Azathioprine—Crohn's disease	0.000359	0.00236	CcSEcCtD
Ceftriaxone—Dermatitis—Azathioprine—Crohn's disease	0.000359	0.00236	CcSEcCtD
Ceftriaxone—Flushing—Prednisone—Crohn's disease	0.000359	0.00236	CcSEcCtD
Ceftriaxone—Headache—Azathioprine—Crohn's disease	0.000357	0.00234	CcSEcCtD
Ceftriaxone—Diarrhoea—Mesalazine—Crohn's disease	0.000355	0.00233	CcSEcCtD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000353	0.00607	CbGpPWpGaD
Ceftriaxone—Dizziness—Mesalazine—Crohn's disease	0.000343	0.00225	CcSEcCtD
Ceftriaxone—ALB—Vitamin B12 Metabolism—MPO—Crohn's disease	0.000339	0.00584	CbGpPWpGaD
Ceftriaxone—Nausea—Azathioprine—Crohn's disease	0.000339	0.00222	CcSEcCtD
Ceftriaxone—Vomiting—Mesalazine—Crohn's disease	0.00033	0.00217	CcSEcCtD
Ceftriaxone—Rash—Mesalazine—Crohn's disease	0.000327	0.00215	CcSEcCtD
Ceftriaxone—Dermatitis—Mesalazine—Crohn's disease	0.000327	0.00215	CcSEcCtD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000326	0.00561	CbGpPWpGaD
Ceftriaxone—Headache—Mesalazine—Crohn's disease	0.000325	0.00214	CcSEcCtD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000319	0.00549	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000319	0.00549	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—F5—Crohn's disease	0.000314	0.00541	CbGpPWpGaD
Ceftriaxone—Ill-defined disorder—Prednisone—Crohn's disease	0.000312	0.00205	CcSEcCtD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000312	0.00537	CbGpPWpGaD
Ceftriaxone—Anaemia—Prednisone—Crohn's disease	0.000311	0.00204	CcSEcCtD
Ceftriaxone—Agitation—Prednisone—Crohn's disease	0.000309	0.00203	CcSEcCtD
Ceftriaxone—Nausea—Mesalazine—Crohn's disease	0.000308	0.00202	CcSEcCtD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—TNF—Crohn's disease	0.000306	0.00526	CbGpPWpGaD
Ceftriaxone—Malaise—Prednisone—Crohn's disease	0.000303	0.00199	CcSEcCtD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000303	0.00521	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—F5—Crohn's disease	0.000299	0.00515	CbGpPWpGaD
Ceftriaxone—Convulsion—Prednisone—Crohn's disease	0.000292	0.00191	CcSEcCtD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000288	0.00496	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000288	0.00495	CbGpPWpGaD
Ceftriaxone—Discomfort—Prednisone—Crohn's disease	0.000283	0.00186	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—PLA2G4F—Crohn's disease	0.000282	0.00485	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—MPO—Crohn's disease	0.000276	0.00475	CbGpPWpGaD
Ceftriaxone—Anaphylactic shock—Prednisone—Crohn's disease	0.000275	0.0018	CcSEcCtD
Ceftriaxone—Oedema—Prednisone—Crohn's disease	0.000275	0.0018	CcSEcCtD
Ceftriaxone—Infection—Prednisone—Crohn's disease	0.000273	0.00179	CcSEcCtD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000269	0.00463	CbGpPWpGaD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000268	0.0046	CbGpPWpGaD
Ceftriaxone—Hyperhidrosis—Prednisone—Crohn's disease	0.000266	0.00174	CcSEcCtD
Ceftriaxone—Cefoperazone—ALB—Crohn's disease	0.000265	0.0282	CrCbGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000255	0.00438	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000255	0.00438	CbGpPWpGaD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—IL6—Crohn's disease	0.000247	0.00425	CbGpPWpGaD
Ceftriaxone—Paraesthesia—Prednisone—Crohn's disease	0.000247	0.00162	CcSEcCtD
Ceftriaxone—Dyspepsia—Prednisone—Crohn's disease	0.000242	0.00159	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—MTMR3—Crohn's disease	0.000239	0.00412	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000238	0.00409	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000235	0.00405	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000235	0.00405	CbGpPWpGaD
Ceftriaxone—Feeling abnormal—Prednisone—Crohn's disease	0.000226	0.00149	CcSEcCtD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000225	0.00387	CbGpPWpGaD
Ceftriaxone—Gastrointestinal pain—Prednisone—Crohn's disease	0.000225	0.00147	CcSEcCtD
Ceftriaxone—ALB—Selenium Micronutrient Network—MPO—Crohn's disease	0.000219	0.00377	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000218	0.00376	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000218	0.00376	CbGpPWpGaD
Ceftriaxone—Urticaria—Prednisone—Crohn's disease	0.000218	0.00143	CcSEcCtD
Ceftriaxone—Cefazolin—ALB—Crohn's disease	0.000218	0.0231	CrCbGaD
Ceftriaxone—Body temperature increased—Prednisone—Crohn's disease	0.000217	0.00143	CcSEcCtD
Ceftriaxone—Abdominal pain—Prednisone—Crohn's disease	0.000217	0.00143	CcSEcCtD
Ceftriaxone—Hypersensitivity—Prednisone—Crohn's disease	0.000202	0.00133	CcSEcCtD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000199	0.00342	CbGpPWpGaD
Ceftriaxone—Pruritus—Prednisone—Crohn's disease	0.000194	0.00128	CcSEcCtD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000194	0.00334	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000194	0.00334	CbGpPWpGaD
Ceftriaxone—Diarrhoea—Prednisone—Crohn's disease	0.000188	0.00123	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—FADS1—Crohn's disease	0.000187	0.00321	CbGpPWpGaD
Ceftriaxone—Dizziness—Prednisone—Crohn's disease	0.000182	0.00119	CcSEcCtD
Ceftriaxone—Cefalotin—ALB—Crohn's disease	0.000181	0.0192	CrCbGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000179	0.00309	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—CRP—Crohn's disease	0.000178	0.00307	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GPX4—Crohn's disease	0.000175	0.00301	CbGpPWpGaD
Ceftriaxone—Vomiting—Prednisone—Crohn's disease	0.000175	0.00115	CcSEcCtD
Ceftriaxone—Rash—Prednisone—Crohn's disease	0.000173	0.00114	CcSEcCtD
Ceftriaxone—Dermatitis—Prednisone—Crohn's disease	0.000173	0.00114	CcSEcCtD
Ceftriaxone—Headache—Prednisone—Crohn's disease	0.000172	0.00113	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—GCKR—Crohn's disease	0.000169	0.0029	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000166	0.00285	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000166	0.00285	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000166	0.00285	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—ICAM1—Crohn's disease	0.000164	0.00282	CbGpPWpGaD
Ceftriaxone—Nausea—Prednisone—Crohn's disease	0.000163	0.00107	CcSEcCtD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000162	0.00279	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000162	0.00279	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000159	0.00273	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000154	0.00265	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000146	0.00252	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—CRP—Crohn's disease	0.000145	0.0025	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—F5—Crohn's disease	0.000139	0.0024	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000137	0.00235	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000136	0.00234	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—ICAM1—Crohn's disease	0.000133	0.0023	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—IFNG—Crohn's disease	0.000125	0.00215	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000121	0.00208	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000117	0.00201	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—CRP—Crohn's disease	0.000115	0.00199	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000114	0.00196	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000112	0.00193	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—IL1B—Crohn's disease	0.000111	0.00192	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	0.000106	0.00182	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000104	0.00179	CbGpPWpGaD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000104	0.00179	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000103	0.00178	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IFNG—Crohn's disease	0.000102	0.00175	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000101	0.00174	CbGpPWpGaD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	9.63e-05	0.00166	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL1B—Crohn's disease	9.06e-05	0.00156	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.86e-05	0.00152	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	8.57e-05	0.00147	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	8.42e-05	0.00145	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	8.42e-05	0.00145	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	8.36e-05	0.00144	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	8.08e-05	0.00139	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	8.08e-05	0.00139	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	8.07e-05	0.00139	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	7.73e-05	0.00133	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	7.2e-05	0.00124	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—F5—Crohn's disease	7.19e-05	0.00124	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	7.15e-05	0.00123	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.9e-05	0.00119	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—TNF—Crohn's disease	6.57e-05	0.00113	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	6.52e-05	0.00112	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.46e-05	0.00111	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.93e-05	0.00102	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	5.85e-05	0.00101	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ALB—Crohn's disease	5.71e-05	0.000982	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ALB—Crohn's disease	5.37e-05	0.000924	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL6—Crohn's disease	5.3e-05	0.000913	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ALB—Crohn's disease	5.27e-05	0.000908	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.25e-05	0.000903	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	5.22e-05	0.000899	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ALB—Crohn's disease	4.89e-05	0.000842	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PTGS2—Crohn's disease	4.7e-05	0.000808	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLA2G4F—Crohn's disease	4.64e-05	0.000798	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ITGA4—Crohn's disease	4.42e-05	0.00076	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	4.35e-05	0.000749	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IL3—Crohn's disease	4.31e-05	0.000741	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	4.21e-05	0.000725	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—RASGRP1—Crohn's disease	4.17e-05	0.000717	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—MTMR3—Crohn's disease	3.94e-05	0.000679	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	3.93e-05	0.000677	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	3.63e-05	0.000625	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—FADS1—Crohn's disease	3.07e-05	0.000529	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IL2RA—Crohn's disease	3.02e-05	0.000519	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GPX4—Crohn's disease	2.88e-05	0.000495	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GCKR—Crohn's disease	2.78e-05	0.000478	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—JAK2—Crohn's disease	2.03e-05	0.000349	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.74e-05	0.000299	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PTGS2—Crohn's disease	7.74e-06	0.000133	CbGpPWpGaD
